Coagulopathy in COVID‐19

The COVID‐19 pandemic has become an urgent issue in every country. Based on recent reports, the most severely ill patients present with coagulopathy, and disseminated intravascular coagulation (DIC)‐like massive intravascular clot formation is frequently seen in this cohort. Therefore, coagulation t...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of thrombosis and haemostasis Ročník 18; číslo 9; s. 2103 - 2109
Hlavní autoři:	Iba, Toshiaki, Levy, Jerrold H., Levi, Marcel, Thachil, Jecko
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Elsevier Limited 01.09.2020 John Wiley and Sons Inc
Témata:	anticoagulant Anticoagulants Antithrombin Biodegradation Blood Coagulation Blood Coagulation Disorders - blood Blood Coagulation Disorders - complications Blood Coagulation Tests Cell death coagulopathy coronavirus COVID-19 COVID-19 - complications COVID-19 - epidemiology Cytokines - metabolism Degradation products Disseminated intravascular coagulation Disseminated Intravascular Coagulation - blood Disseminated Intravascular Coagulation - complications Fibrin Fibrin - chemistry Fibrin Fibrinogen Degradation Products - metabolism Fibrinogen Fibrinogen - chemistry Fibrinolysis Hemorrhage Hemostasis Humans Hypoxia Immune response Inflammation Lung - metabolism Lung - virology Lymphocytes Lymphocytes - metabolism Pandemics Partial Thromboplastin Time Protease Inhibitors Prothrombin Prothrombin Time Review Sepsis Thrombocytopenia Thromboembolism Thromboplastin Thrombosis Thrombosis - metabolism COVID-19 coronavirus anticoagulant coagulopathy disseminated intravascular coagulation
ISSN:	1538-7933, 1538-7836, 1538-7836
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!